Oleic acid and hydroxytyrosol inhibit cholesterol and fatty acid synthesis in C6 glioma cells

Oxidative Medicine and Cellular Longevity

Volumn 2017, Issue , 2017, Pages

  Priore, Paola ^a   Gnoni, Antonio ^b   Natali, Francesco ^a   Testini, Mariangela ^a   Gnoni, Gabriele V ^a   Siculella, Luisa ^a   Damiano, Fabrizio ^a  

^a UNIVERSITY OF SALENTO   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOSYNTHESIS; CELLS; CHOLESTEROL; OLEIC ACID; OLIVE OIL; TUMORS;

ACETYL-COA CARBOXYLASE; CHOLESTEROL SYNTHESIS; EXTRA VIRGIN OLIVE OIL; FATTY ACID BIOSYNTHESIS; FATTY ACID SYNTHASE; FATTY ACID SYNTHESIS; INHIBITORY EFFECT; NATURAL COMPOUNDS;

CYTOLOGY;

ACETYL COENZYME A CARBOXYLASE; CHOLESTEROL; DIGITONIN; FATTY ACID; FATTY ACID SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYTYROSOL; MESSENGER RNA; OLEIC ACID; TRIACYLGLYCEROL; 3,4-DIHYDROXYPHENYLETHANOL; HYPOCHOLESTEROLEMIC AGENT; OLIVE OIL; PHENETHYL ALCOHOL;

ARTICLE; CELL PERMEABILIZATION; CELL VIABILITY; CHOLESTEROL SYNTHESIS; DRUG MECHANISM; FATTY ACID SYNTHESIS; GLIOMA; GLIOMA CELL; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECT; LIPID METABOLISM; METABOLISM; RAT; TUMOR CELL LINE;

CELLS; ENZYMES; FATTY ACIDS; OLEIC ACID; STEROLS;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CELL LINE, TUMOR; CHOLESTEROL; FATTY ACID SYNTHASES; GLIOMA; LIPID METABOLISM; OLEIC ACID; OLIVE OIL; PHENYLETHYL ALCOHOL; RATS;

EID: 85042226669     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2017/9076052     Document Type: Article

References (55)

1. E. Toledo, J. Salas-Salvadó, C. Donat-Vargas et al., "Mediterranean diet and invasive breast cancer risk among women at high cardiovascular risk in the PREDIMED trial: a randomized clinical trial," JAMA Internal Medicine, vol. 175, no. 11, pp. 1752-1760, 2015.
2. M. Á. Martínez-González, M. Ruiz-Canela, A. Hruby, L. Liang, A. Trichopoulou, and F. B. Hu, "Intervention trials with the Mediterranean diet in cardiovascular prevention: understanding potential mechanisms through metabolomic profiling," The Journal of Nutrition, vol. 146, no. 4, pp. 913S-919S, 2016.
3. J. Rodríguez-Morató, L. Xicota, M. Fitó, M. Farré, M. Dierssen, and R. de la Torre, "Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases," Molecules, vol. 20, no. 3, pp. 4655-4680, 2015.
4. L. Fernández del Río, E. Gutiérrez-Casado, A. Varela-López, and J. Villalba, "Olive oil and the hallmarks of aging," Molecules, vol. 21, no. 2, p. 163, 2016.
5. F. Natali, L. Siculella, S. Salvati, and G. V. Gnoni, "Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells," The Journal of Lipid Research, vol. 48, no. 9, pp. 1966-1975, 2007.
6. P. Priore, A. Cavallo, A. Gnoni, F. Damiano, G. V. Gnoni, and L. Siculella, "Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver disease," IUBMB Life, vol. 67, no. 1, pp. 9-17, 2015.
7. E. Lei, K. Vacy, and W. C. Boon, "Fatty acids and their therapeutic potential in neurological disorders," Neurochemistry International, vol. 95, pp. 75-84, 2016.
8. M. Piroddi, A. Albini, R. Fabiani et al., "Nutrigenomics of extra-virgin olive oil: a review," BioFactors, vol. 43, no. 1, pp. 17-41, 2017.
9. R. Fabiani, "Anti-cancer properties of olive oil secoiridoid phenols: a systematic review of in vivo studies," Food & Function, vol. 7, no. 10, pp. 4145-4159, 2016.
10. C. C. Tangney and H. E. Rasmussen, "Polyphenols, inflammation, and cardiovascular disease," Current Atherosclerosis Reports, vol. 15, no. 5, p. 324, 2013.
11. F. Visioli, G. Bellomo, and C. Galli, "Free radical-scavenging properties of olive oil polyphenols," Biochemical and Biophysical Research Communications, vol. 247, no. 1, pp. 60-64, 1998.
12. P. Priore, L. Siculella, and G. V. Gnoni, "Extra virgin olive oil phenols down-regulate lipid synthesis in primary-cultured rat-hepatocytes," The Journal of Nutritional Biochemistry, vol. 25, no. 7, pp. 683-691, 2014.
13. P. Priore, D. Caruso, L. Siculella, and G. V. Gnoni, "Rapid down-regulation of hepatic lipid metabolism by phenolic fraction from extra virgin olive oil," European Journal of Nutrition, vol. 54, no. 5, pp. 823-833, 2015.
14. W. J. Lukiw, M. Pappolla, R. P. Pelaez, and N. G. Bazan, "Alzheimer's disease-a dysfunction in cholesterol and lipid metabolism," Cellular and Molecular Neurobiology, vol. 25, no. 3-4, pp. 475-483, 2005.
15. A. Romano, J. B. Koczwara, C. A. Gallelli et al., "Fats for thoughts: an update on brain fatty acid metabolism," The International Journal of Biochemistry & Cell Biology, vol. 84, pp. 40-45, 2017.
16. C. Féart, C. Samieri, V. Rondeau et al., "Adherence to a Mediterranean diet, cognitive decline, and risk of dementia," JAMA, vol. 302, no. 6, pp. 638-648, 2009.
17. V. Pitozzi, M. Jacomelli, M. Zaid et al., "Effects of dietary extravirgin olive oil on behaviour and brain biochemical parameters in ageing rats," British Journal of Nutrition, vol. 103, no. 11, pp. 1674-1683, 2010.
18. D. Pantano, I. Luccarini, P. Nardiello, M. Servili, M. Stefani, and F. Casamenti, "Oleuropein aglycone and polyphenols from olive mill waste water ameliorate cognitive deficits and neuropathology," British Journal of Clinical Pharmacology, vol. 83, no. 1, pp. 54-62, 2017.
19. S. Torres, M. Lorente, F. Rodríguez-Fornés et al., "A combined preclinical therapy of cannabinoids and temozolomide against glioma," Molecular Cancer Therapeutics, vol. 10, no. 1, pp. 90-103, 2011.
20. I. Matias, A. S. Buosi, and F. C. A. Gomes, "Functions of flavonoids in the central nervous system: astrocytes as targets for natural compounds," Neurochemistry International, vol. 95, pp. 85-91, 2016.
21. J. J. Volpe, K. Fujimoto, J. C. Marasa, and H. C. Agrawal, "Relation of C-6 glial cells in culture to myelin," The Biochemical Journal, vol. 152, no. 3, pp. 701-703, 1975.
22. F. A. McMorris, "Norepinephrine induces glial-specific enzyme activity in cultured plasma glioma cells," Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 10, pp. 4501-4504, 1977.
23. K. A. Nave and G. Lemke, "Induction of the myelin proteolipid protein (PLP) gene in C6 glioblastoma cells: functional analysis of the PLP promotor," The Journal of Neuroscience, vol. 11, no. 10, pp. 3060-3069, 1991.
24. A. Quincozes-Santos, L. D. Bobermin, A. Latini et al., "Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1," PLoS One, vol. 8, no. 5, article e64372, 2013.
25. G. V. Gnoni, M. J. H. Geelen, C. Bijleveld, E. Quagliariello, and S. G. van den Bergh, "Short-term stimulation of lipogenesis by triiodothyronine in maintenance cultures of rat hepatocytes," Biochemical and Biophysical Research Communications, vol. 128, no. 2, pp. 525-530, 1985.
26. E. G. Bligh and W. J. Dyer, "A rapid method of total lipid extraction and purification," Canadian Journal of Biochemistry and Physiology, vol. 37, no. 1, pp. 911-917, 1959.
27. M. J. H. Geelen, "The use of digitonin-permeabilized mammalian cells for measuring enzyme activities in the course of studies on lipid metabolism," Analytical Biochemistry, vol. 347, no. 1, pp. 1-9, 2005.
28. P. Priore, A. M. Giudetti, F. Natali, G. V. Gnoni, and M. J. H. Geelen, "Metabolism and short-term metabolic effects of conjugated linoleic acids in rat hepatocytes," Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1771, no. 10, pp. 1299-1307, 2007.
29. F. Damiano, R. Tocci, G. V. Gnoni, and L. Siculella, "Expression of citrate carrier gene is activated by ER stress effectors XBP1 and ATF6a, binding to an UPRE in its promoter," Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, vol. 1849, no. 1, pp. 23-31, 2015.
30. L. Siculella, R. Tocci, A. Rochira, M. Testini, A. Gnoni, and F. Damiano, "Lipid accumulation stimulates the capindependent translation of SREBP-1a mRNA by promoting hnRNP A1 binding to its 5'-UTR in a cellular model of hepatic steatosis," Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1861, no. 5, pp. 471-481, 2016.
31. E. Scoditti, N. Calabriso, M. Massaro et al., "Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer," Archives of Biochemistry and Biophysics, vol. 527, no. 2, pp. 81-89, 2012.
32. E. Scoditti, A. Nestola, M. Massaro et al., "Hydroxytyrosol suppresses MMP-9 and COX-2 activity and expression in activated human monocytes via PKCa and PKCβ1 inhibition," Atherosclerosis, vol. 232, no. 1, pp. 17-24, 2014.
33. N. Scarmeas, Y. Stern, M. X. Tang, R. Mayeux, and J. A. Luchsinger, "Mediterranean diet and risk for Alzheimer's disease," Annals of Neurology, vol. 59, no. 6, pp. 912-921, 2006.
34. R. W. Mitchell, N. H. On, M. R. Del Bigio, D. W. Miller, and G. M. Hatch, "Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells," Journal of Neurochemistry, vol. 117, no. 4, pp. 735-746, 2011.
35. J. Zhang and Q. Liu, "Cholesterol metabolism and homeostasis in the brain," Protein & Cell, vol. 6, no. 4, pp. 254-264, 2015.
36. M. Madra and S. L. Sturley, "Niemann-Pick type C pathogenesis and treatment: from statins to sugars," Clinical Lipidology, vol. 5, no. 3, pp. 387-395, 2010.
37. N. Sato and R. Morishita, "The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease," Frontiers in Aging Neuroscience, vol. 7, p. 199, 2015.
38. R. C. Block, E. R. Dorsey, C. A. Beck, J. T. Brenna, and I. Shoulson, "Altered cholesterol and fatty acid metabolism in Huntington disease," Journal of Clinical Lipidology, vol. 4, no. 1, pp. 17-23, 2010.
39. M. Doria, L. Maugest, T. Moreau, G. Lizard, and A. Vejux, "Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease," Free Radical Biology & Medicine, vol. 101, pp. 393-400, 2016.
40. N. D. Perera and B. J. Turner, "AMPK signalling and defective energy metabolism in amyotrophic lateral sclerosis," Neurochemical Research, vol. 41, no. 3, pp. 544-553, 2016.
41. P. Prasanna, A. Thibault, L. Liu, and D. Samid, "Lipid metabolism as a target for brain cancer therapy: synergistic activity of lovastatin and sodium phenylacetate against human glioma cells," The Journal of Neurochemistry, vol. 66, no. 2, pp. 710-716, 1996.
42. M. Tuohetahuntila, M. R. Molenaar, B. Spee et al., "ATGL and DGAT1 are involved in the turnover of newly synthesized triacylglycerols in hepatic stellate cells," Journal of Lipid Research, vol. 57, no. 7, pp. 1162-1174, 2016.
43. J. E. C. Sykes and M. Lopes-Cardozo, "Effect of exogenous fatty acids on lipid synthesis, marker-enzymes, and development of glial cells maintained in serum-free culture," Glia, vol. 3, no. 6, pp. 495-501, 1990.
44. F. Leonardi, L. Attorri, R. D. Benedetto et al., "Effect of arachidonic, eicosapentaenoic and docosahexaenoic acids on the oxidative status of C6 glioma cells," Free Radical Research, vol. 39, no. 8, pp. 865-874, 2005.
45. C. F. Semenkovich, "Regulation of fatty acid synthase (FAS)," Progress in Lipid Research, vol. 36, no. 1, pp. 43-53, 1997.
46. F. Echeverría, M. Ortiz, R. Valenzuela, and L. A. Videla, "Hydroxytyrosol and cytoprotection: a projection for clinical interventions," The International Journal of Biochemistry & Cell Biology, vol. 18, no. 5, article e930, 2017.
47. A. M. Giudetti, F. Damiano, G. V. Gnoni, and L. Siculella, "Low level of hydrogen peroxide induces lipid synthesis in BRL-3A cells through a CAP-independent SREBP-1a activation," The International Journal of Biochemistry & Cell Biology, vol. 45, no. 7, pp. 1419-1426, 2013.
48. L. Liu, K. Zhang, H. Sandoval et al., "Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration," Cell, vol. 160, no. 1-2, pp. 177-190, 2015.
49. W. Shao and P. J. Espenshade, "Expanding roles for SREBP in metabolism," Cell Metabolism, vol. 16, no. 4, pp. 414-419, 2012.
50. F. Damiano, A. Rochira, R. Tocci, S. Alemanno, A. Gnoni, and L. Siculella, "HnRNP A1 mediates the activation of the IRES-dependent SREBP-1a mRNA translation in response to endoplasmic reticulum stress," Biochemical Journal, vol. 449, no. 2, pp. 543-553, 2013.
51. F. Visioli, C. Galli, F. Bornet et al., "Olive oil phenolics are dose-dependently absorbed in humans," FEBS Letters, vol. 46, no. 2-3, pp. 159-160, 2000.
52. R. de la Torre, "Bioavailability of olive oil phenolic compounds in humans," Inflammopharmacology, vol. 16, no. 5, pp. 245-247, 2008.
53. F. Visioli and C. Galli, "Olive oil: more than just oleic acid," The American Journal of Clinical Nutrition, vol. 72, no. 3, p. 853, 2000.
54. E. Miro-Casas, M. I. Covas, M. Farre et al., "Hydroxytyrosol disposition in humans," Clinical Chemistry, vol. 49, no. 6, pp. 945-952, 2003.
55. M. I. Covas, K. de la Torre, M. Farré-Albaladejo et al., "Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans," Free Radical Biology & Medicine, vol. 40, no. 4, pp. 608-616, 2006.